Business
Press Release Mar 13 2026
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Potassium Phosphates Injection USP".
About this update from Caplin Point Laboratories Limited
[{"type":"text","content":" Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2026, titled \"Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Potassium Phosphates Injection USP\". View Attachment","length":398,"tagName":"div"}]